Newron Pharmaceuticals Market Cap

Newron Pharmaceuticals has a market cap or net worth of €425.65 million as of January 30, 2026. Its market cap has increased by 125.27% in one year.

Market Cap

425.65M

Enterprise Value

435.21M

Revenue

59.88M

Ranking

n/a

PE Ratio

16.81

Stock Price

€21.80

Market Cap Chart

Since December 12, 2006, Newron Pharmaceuticals's market cap has increased from 194.15M to 425.65M, an increase of 119.23%. That is a compound annual growth rate of 4.18%.

Market Cap History

Date	Market Cap	% Change
Jan 30, 2026	425.65M	-16.85%
Dec 30, 2025	511.90M	176.62%
Dec 30, 2024	185.06M	94.99%
Dec 29, 2023	94.91M	239.07%
Dec 30, 2022	27.99M	0.21%
Dec 30, 2021	27.93M	-20.96%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Paul Hartmann AG	777.83M
EUROKAI GmbH & Co. KGaA	688.26M
FRoSTA Aktiengesellschaft	656.73M
Südwestdeutsche Salzwerke AG	640.96M
Wild Bunch AG	531.53M
HOMAG Group AG	414.16M
Eisen- und Hüttenwerke AG	387.20M
Novabase S.G.P.S.	352.86M

Market Cap Rankings